Intervention Protocol

Outpatient treatment for patients with cancer who develop a low-risk febrile neutropenic event

  1. Rodolfo Rivas-Ruiz1,*,
  2. Miguel Villasis-Keever2,
  3. Maria G Miranda-Novales3

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 16 MAR 2011

DOI: 10.1002/14651858.CD009031


How to Cite

Rivas-Ruiz R, Villasis-Keever M, Miranda-Novales MG. Outpatient treatment for patients with cancer who develop a low-risk febrile neutropenic event (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD009031. DOI: 10.1002/14651858.CD009031.

Author Information

  1. 1

    Insitiuto Mexicano del Seguro Social, Centro Medico Nacional Siglo XXI, Colonia Doctores, Mexico

  2. 2

    Instituto Mexicano del Seguro Social, Clinical Epidemiology Research Unit, Mexico City, DF, Mexico

  3. 3

    Centro Medico Nacional Siglo XXI, Avenida Cuauhtemoc #330, Colonia Doctores, Mexico

*Rodolfo Rivas-Ruiz, Insitiuto Mexicano del Seguro Social, Centro Medico Nacional Siglo XXI, Hospital de Pediatra., Avenida Cuauhtemoc #330, Colonia Doctores, Mexico. rivasrodolfo@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 16 MAR 2011

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  • To compare the efficacy of outpatient empirical antimicrobial therapy versus in-hospital treatment of low-risk febrile neutropenic cancer patients.

Secondary objective

  • To compare the rate of adverse effects of outpatient empirical antimicrobial therapy versus in-hospital treatment of low-risk febrile neutropenic cancer patients.